The world's latest technology in cervical screening. Learn more
Director and Officer disclosure notice for former director Christopher Lawrence.
TruScreen Group Limited (NZX/ASX: TRU) (TruScreen or the Company) is pleased to advise that it has received its first order from Serbia, Eastern Europe.
Directors and Officer Disclosure Notice - Former Director Christopher Lawrence.
TruScreen CEO, Juliet Hull, recently sat down with Stuart Roberts from Stocks Down Under.
Director and Officer Disclosure notice for former director, Christopher Lawrence.
Cervical cancer technology company Truscreen Group Limited has released its preliminary unaudited financial results for the year ended 31 March 2021.
Researchers in China explored the impact of using TruScreen cervical cancer screening device in the absence of colposcopy and PAP facilities and commented on the…